Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolenium versus Seretide Diskus single-dose crossover study in adults with asthma
2007-006670-29Phase 3Completed
- Sponsor
- ELPEN
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salmeterol + fluticasone in asthma (2 arms), sponsored by ELPEN. Primary endpoint: 12-hour average FEV1. Started Jan 2008; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-006670-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006670-29.